[ad_1]
In December 2021, Kyrgyzstan started a venture to leverage its high-quality surveillance system for extreme acute respiratory infections (SARI) to evaluate the vaccine effectiveness of COVID-19 and influenza vaccines.
From early within the COVID-19 pandemic, WHO suggested international locations to make use of hospital-based sentinel surveillance methods initially established for influenza to additionally monitor SARS-CoV-2. These platforms will also be tailored to watch the continuing effectiveness of COVID-19 and influenza vaccines in stopping infections requiring hospitalization amongst SARI sufferers. Frequently assessing vaccine effectiveness is especially vital given the elevated dangers posed by rising SARS-CoV-2 variants of concern and the uncertainties about how lengthy vaccine safety lasts, amongst different issues. This will additionally strengthen routine monitoring of influenza vaccine effectiveness.
For nearly a decade, Kyrgyzstan has labored to enhance sentinel surveillance of Influenza-like sickness (ILI) and SARI to tell coverage choices associated to influenza management within the nation. This work has been supported by the PIP Framework Partnership Contribution and Kyrgyzstan has proven exceptional progress in making certain consultant and high-quality sentinel influenza surveillance information. Quickly after the COVID-19 pandemic started, Kyrgyzstan built-in COVID-19 monitoring into its sentinel influenza surveillance system, as advisable by WHO, and so has secured the continued monitoring of tendencies in circulation, virus traits and severity of illness. Now the nation has additionally tailored its epidemiological and laboratory SARI surveillance to allow periodic evaluation of the effectiveness of COVID-19 and influenza vaccines.
The outcomes of the vaccine effectiveness monitoring will assist programmatic choices about COVID-19 and influenza vaccination methods in Kyrgyzstan. They will even contribute to a pooled information evaluation overseen by WHO that integrates information from SARI websites throughout a number of international locations.
Kyrgyzstan’s success story relies on harnessing an present SARI sentinel surveillance system that was strengthened below the PIP Framework Partnership Contribution. The capability constructing efforts undertaken over the previous seven years to enhance the standard and completeness of sentinel surveillance information are exhibiting their worth. The improved SARI surveillance system gives an efficient framework for vaccine effectiveness estimates and gives important enter to coverage choices associated to influenza and now additionally COVID-19 illness management in Kyrgyzstan. As such, the SARI surveillance methods and the vaccine effectiveness monitoring present a cornerstone within the COVID-19 response and within the preparedness for future seasonal and pandemic influenza.
[ad_2]
Source link
